查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1807411

早期癌症检测·监测用液态生物检体的全球市场:市场规模·占有率·趋势，产业分析 (生物标记·癌症·各技术·各最终用途·各地区)，2025年～2034年的市场预测

Liquid Biopsy for Early Cancer Detection and Monitoring Market Size, Share, Trends, Industry Analysis Report By Biomarker, By Cancer, By Technology, By End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 最近的一项研究，预计到 2034 年，用于早期癌症检测和监测的液体活检市场规模将达到 65.3 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

液体活检是一种非侵入性诊断工具，可检测体液（主要是血液）中的癌症相关生物标记物，从而实现早期癌症检测和监测。与需要外科手术的传统组织切片不同，液体切片分析的是循环肿瘤 DNA (ctDNA)、循环肿瘤细胞 (CTC)、外泌体或其他释放到血液中的癌症衍生分子。该方法提供了一种微创、快速且可重复的方法，用于识别肿瘤相关的基因突变、表观遗传学改变和蛋白质特征。液体活检尤其适用于早期癌症检测，可在出现症状或影像学检查发现肿瘤之前识别恶性肿瘤。液体切片检查也用于监测治疗反应、检测微小残留病灶 (MRD) 并即时追踪肿瘤进展，帮助临床医生根据分子变化製定个人化治疗方案。

液体活检的应用涵盖各种临床场景，包括筛检高风险族群、指导个人化治疗以及比传统方法更早发现復发。在肺癌领域，液体切片正在识别 EGFR 突变，从而客製化酪胺酸激酶抑制剂治疗方案。在大肠直肠癌领域，液体活检有助于监测 KRAS 突变，以确定治疗抗药性。新一代定序 (NGS) 和人工智慧驱动的数据分析的进步正在提高液体活检的准确性和可扩展性。

用于早期癌症检测和监测的液体活检市场：分析概述

就生物标记而言，循环肿瘤DNA (ctDNA) 细分市场预计将占 2024 年 32.31% 的收入占有率，这得益于其高灵敏度、广泛适用于各种癌症类型以及检测微小残留病灶和肿瘤异质性的能力。

按癌症类型划分，肺癌在 2024 年占了相当大的收入占有率，这得益于其高发病率、早期检测的需求以及组织活检和影像学等传统诊断方法的局限性。

就技术而言，新一代定序 (NGS) 凭藉其高灵敏度和特异性同时分析多种基因变异的能力，在 2024 年占了主导地位。

按最终用途划分，预计诊断实验室细分市场将在未来几年保持强劲增长。这些实验室提供专业知识、经济高效的检测解决方案和较短的周转时间，对医生和患者都具有吸引力。

预计到 2024 年，北美用于早期癌症检测和监测的液体活检市场将占全球收入的 37.15%。这种主导地位归因于癌症的高发病率、非侵入性诊断技术的日益普及以及强大的医疗保健基础设施。

全球早期癌症检测和监测液体活检市场的领先公司包括 AnchorDx, Inc.、Burning Rock Biotech Limited、Elypta AB、Exact Sciences Corporation、Freenome Holdings, Inc.、GENEC, Inc.、Illumina, Inc.、Guardant Health、Lucence Health、Myriad Genetics, Inc. 和 Oncipune, Inc.

目录

第1章 简介

第2章 摘要整理

第3章 分析方法

第4章 全球早期癌症检测·监测用液态生物检体市场洞察

  • 市场概述
  • 早期癌症检测·监测用液态生物检体的市场动态
    • 促进因素和机会
      • 癌症发生率上升
      • 监管支持力道加大
    • 阻碍因素和课题
      • 检测低浓度肿瘤衍生物质的敏感度有限
  • 大环境分析
  • 早期癌症检测·监测用液态生物检体市场趋势
  • 价值链分析

第5章 全球早期癌症检测·监测用液态生物检体市场:生物标记

  • 主要的分析结果
  • 简介
  • 循环肿瘤DNA (ctDNA)
  • 循环肿瘤细胞 (CTC)
  • 外泌体/微囊泡
  • 循环蛋白质

第6章 全球早期癌症检测·监测用液态生物检体市场:癌症

  • 主要的分析结果
  • 简介
  • 肺癌症
  • 乳癌
  • 大肠癌症
  • 前列腺癌症
  • 其他

第7章 全球早期癌症检测·监测用液态生物检体市场:各技术

  • 主要的分析结果
  • 简介
  • 次世代定序(NGS)
  • PCR为基础的化验
  • 微阵列
  • 表观基因/甲基化化验
  • 其他

第8章 全球早期癌症检测·监测用液态生物检体市场:各最终用途

  • 主要的分析结果
  • 简介
  • 医院
  • 诊断检验室
  • 其他

第9章 全球早期癌症检测·监测用液态生物检体市场:各地区

  • 主要的分析结果
  • 简介
    • 早期癌症检测·监测用液态生物检体市场分析:各地区 (2020～2034年)
  • 北美
    • 北美:各生物标记(2020～2034年)
    • 北美:各癌症(2020～2034年)
    • 北美:各技术(2020～2034年)
    • 北美:各最终用途(2020～2034年)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各生物标记(2020～2034年)
    • 欧洲:各癌症(2020～2034年)
    • 欧洲:各技术(2020～2034年)
    • 欧洲:各最终用途(2020～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各生物标记(2020～2034年)
    • 亚太地区:各癌症(2020～2034年)
    • 亚太地区:各技术(2020～2034年)
    • 亚太地区:各最终用途(2020～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各生物标记(2020～2034年)
    • 中东·非洲:各癌症(2020～2034年)
    • 中东·非洲:各技术(2020～2034年)
    • 中东·非洲:各最终用途(2020～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各生物标记(2020～2034年)
    • 南美:各癌症(2020～2034年)
    • 南美:各技术(2020～2034年)
    • 南美:各最终用途(2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第10章 竞争情形

  • 事业扩大·企业收购的分析
    • 事业扩大
    • 企业收购
  • 联盟/合作/协定/公开

第11章 企业简介

  • AnchorDx
  • Burning Rock Biotech Limited
  • Elypta AB
  • Exact Sciences Corporation
  • Freenome Holdings, Inc.
  • GENECAST
  • Guardant Health
  • Illumina, Inc.
  • Lucence Health Inc.
  • Myriad Genetics, Inc.
  • M42
  • Oncimmune
Product Code: PM6201

The liquid biopsy for early cancer detection and monitoring market size is expected to reach USD 6.53 billion by 2034, according to a new study by Polaris Market Research. The report "Liquid Biopsy for Early Cancer Detection and Monitoring Market Share, Size, Trends, Industry Analysis Report By Biomarker [Circulating Tumor DNA (ctDNA), Circulating Tumor Cells (CTCs)], By Cancer, By Technology, By End Use, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Liquid biopsy is a noninvasive diagnostic tool that detects cancer-related biomarkers in bodily fluids, primarily blood, to enable early cancer detection and monitoring. Unlike traditional tissue biopsies, which require surgical procedures, liquid biopsies analyze circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, or other cancer-derived molecules released into the bloodstream. This approach offers a less invasive, faster, and repeatable method for identifying genetic mutations, epigenetic changes, and protein signatures associated with tumors. Liquid biopsies are particularly valuable for early cancer detection, as they identify malignancies before symptoms appear or imaging tests reveal tumors. They are also used to monitor treatment response, detect minimal residual disease (MRD), and track tumor evolution in real-time, helping clinicians adjust therapies based on molecular changes.

The usage of liquid biopsies spans various clinical scenarios, including screening high-risk individuals, guiding personalized treatment, and detecting relapse earlier than conventional methods. In lung cancer, liquid biopsies identify EGFR mutations to tailor tyrosine kinase inhibitor therapy. In colorectal cancer, they help monitor KRAS mutations for resistance to treatment. Advancements in next-generation sequencing (NGS) and AI-driven data analysis are enhancing the accuracy and scalability of liquid biopsy.

Liquid Biopsy for Early Cancer Detection and Monitoring Market Report Highlights

In terms of biomarker, the circulating tumor DNA (ctDNA) segment held 32.31% of the revenue share in 2024 due to its high sensitivity, broad applicability across cancer types, and ability to detect minimal residual disease and tumor heterogeneity.

Based on cancer, the lung cancer segment accounted for a major revenue share in 2024 due to the high incidence of the disease, need for early detection, and the limitations of traditional diagnostic methods such as tissue biopsy and imaging.

In terms of technology, the next-generation sequencing (NGS) segment dominated the revenue share in 2024 due to its capability to analyze multiple genetic alterations simultaneously with high sensitivity and specificity.

Based on end use, the diagnostic laboratories segment is projected to grow at a robust pace in the coming years. These laboratories offer specialized expertise, cost-effective testing solutions, and shorter turnaround times, making them attractive for both physicians and patients.

The North America liquid biopsy for early cancer detection and monitoring market accounted for 37.15% of global revenue share in 2024. This dominance is attributed to the high prevalence of cancer, increasing adoption of noninvasive diagnostic techniques, and strong healthcare infrastructure.

A few global key players in the liquid biopsy for early cancer detection and monitoring market include AnchorDx; Burning Rock Biotech Limited; Elypta AB; Exact Sciences Corporation; Freenome Holdings, Inc.; GENECAST; Illumina, Inc.; Guardant Health; Lucence Health Inc.; Myriad Genetics, Inc.; and Oncimmune.

Polaris Market Research has segmented the liquid biopsy for early cancer detection and monitoring market report on the basis of biomarker, cancer, technology, end use, and region:

By Biomarker Outlook (Revenue, USD Billion, 2020-2034)

Circulating Tumor DNA (ctDNA)

Circulating Tumor Cells (CTCs)

Exosomes/Microvesicles

Circulating Proteins

By Cancer Outlook (Revenue, USD Billion, 2020-2034)

Lung Cancer

Breast Cancer

Colorectal Cancer

Prostate Cancer

Others

By Technology Outlook (Revenue, USD Billion, 2020-2034)

Next-Generation Sequencing (NGS)

PCR-based assays

Microarray

Epigenomics / Methylation assays

Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Diagnostic Laboratories

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market Insights

  • 4.1. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Market Snapshot
  • 4.2. Liquid Biopsy for Early Cancer Detection and Monitoring Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Cancer Incidence
      • 4.2.1.2. Growing Regulatory Support
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited sensitivity in detecting low levels of tumor-derived material
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Liquid Biopsy for Early Cancer Detection and Monitoring Market Trends
  • 4.6. Value Chain Analysis

5. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • 5.3. Circulating Tumor DNA (ctDNA)
    • 5.3.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Circulating Tumor DNA (ctDNA), by Region, 2020-2034 (USD Billion)
  • 5.4. Circulating Tumor Cells (CTCs)
    • 5.4.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Circulating Tumor Cells (CTCs), by Region, 2020-2034 (USD Billion)
  • 5.5. Exosomes/Microvesicles
    • 5.5.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Exosomes/Microvesicles, by Region, 2020-2034 (USD Billion)
  • 5.6. Circulating Proteins
    • 5.6.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Circulating Proteins, by Region, 2020-2034 (USD Billion)

6. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • 6.3. Lung Cancer
    • 6.3.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Lung Cancer, by Region, 2020-2034 (USD Billion)
  • 6.4. Breast Cancer
    • 6.4.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Breast Cancer, by Region, 2020-2034 (USD Billion)
  • 6.5. Colorectal Cancer
    • 6.5.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Colorectal Cancer, by Region, 2020-2034 (USD Billion)
  • 6.6. Prostate Cancer
    • 6.6.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Prostate Cancer, by Region, 2020-2034 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • 7.3. Next-Generation Sequencing (NGS)
    • 7.3.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Next-Generation Sequencing (NGS), by Region, 2020-2034 (USD Billion)
  • 7.4. PCR-based assays
    • 7.4.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by PCR-based assays, by Region, 2020-2034 (USD Billion)
  • 7.5. Microarray
    • 7.5.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Microarray, by Region, 2020-2034 (USD Billion)
  • 7.6. Epigenomics / Methylation assays
    • 7.6.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Epigenomics / Methylation assays, by Region, 2020-2034 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 8.4. Diagnostic Laboratories
    • 8.4.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Liquid Biopsy for Early Cancer Detection and Monitoring Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Liquid Biopsy for Early Cancer Detection and Monitoring Market - North America
    • 9.3.1. North America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
    • 9.3.2. North America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
    • 9.3.3. North America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
    • 9.3.4. North America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.5. Liquid Biopsy for Early Cancer Detection and Monitoring Market - US
      • 9.3.5.1. US: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.6. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Canada
      • 9.3.6.1. Canada: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • 9.4. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Europe
    • 9.4.1. Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.5. Liquid Biopsy for Early Cancer Detection and Monitoring Market - UK
      • 9.4.5.1. UK: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.6. Liquid Biopsy for Early Cancer Detection and Monitoring Market - France
      • 9.4.6.1. France: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.7. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Germany
      • 9.4.7.1. Germany: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.8. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Italy
      • 9.4.8.1. Italy: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.9. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Spain
      • 9.4.9.1. Spain: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.10. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Netherlands
      • 9.4.10.1. Netherlands: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.11. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Russia
      • 9.4.11.1. Russia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.12. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • 9.5. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Asia Pacific
    • 9.5.1. Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.5. Liquid Biopsy for Early Cancer Detection and Monitoring Market - China
      • 9.5.5.1. China: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.6. Liquid Biopsy for Early Cancer Detection and Monitoring Market - India
      • 9.5.6.1. India: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.7. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Malaysia
      • 9.5.7.1. Malaysia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.8. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Japan
      • 9.5.8.1. Japan: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.9. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Indonesia
      • 9.5.9.1. Indonesia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.10. Liquid Biopsy for Early Cancer Detection and Monitoring Market - South Korea
      • 9.5.10.1. South Korea: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.11. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Australia
      • 9.5.11.1. Australia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.12. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • 9.6. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.5. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.6. Liquid Biopsy for Early Cancer Detection and Monitoring Market - UAE
      • 9.6.6.1. UAE: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.7. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Israel
      • 9.6.7.1. Israel: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.8. Liquid Biopsy for Early Cancer Detection and Monitoring Market - South Africa
      • 9.6.8.1. South Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.9. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • 9.7. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Latin America
    • 9.7.1. Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.5. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Mexico
      • 9.7.5.1. Mexico: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.6. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Brazil
      • 9.7.6.1. Brazil: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.7. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Argentina
      • 9.7.7.1. Argentina: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.8. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. AnchorDx
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Burning Rock Biotech Limited
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Elypta AB
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Exact Sciences Corporation
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Freenome Holdings, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. GENECAST
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Guardant Health
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Illumina, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Lucence Health Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Myriad Genetics, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. M42
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Oncimmune
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development

List of Tables:

  • Table 1 Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 2 Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 3 Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 4 Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 5 North America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 6 North America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 7 North America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 8 North America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 9 U.S.: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 10 U.S.: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 11 U.S.: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 12 U.S.: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Canada: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 14 Canada: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 15 Canada: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 16 Canada: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 17 Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 18 Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 19 Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 20 Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 21 UK: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 22 UK: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 23 UK: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 24 UK: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 France: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 26 France: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 27 France: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 28 France: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 29 Germany: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 30 Germany: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 31 Germany: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 32 Germany: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 33 Italy: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 34 Italy: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 35 Italy: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 36 Italy: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Spain: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 38 Spain: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 39 Spain: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 40 Spain: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 45 Russia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 46 Russia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 47 Russia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 48 Russia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 57 China: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 58 China: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 59 China: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 60 China: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 India: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 62 India: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 63 India: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 64 India: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 69 Japan: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 70 Japan: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 71 Japan: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 72 Japan: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 77 South Korea: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 78 South Korea: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 79 South Korea: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 80 South Korea: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 81 Australia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 82 Australia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 83 Australia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 84 Australia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 UAE: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 98 UAE: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 99 UAE: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 100 UAE: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 101 Israel: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 102 Israel: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 103 Israel: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 104 Israel: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 105 South Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 106 South Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 107 South Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 108 South Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 113 Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 114 Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 115 Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 116 Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 117 Mexico: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 118 Mexico: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 119 Mexico: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 120 Mexico: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 121 Brazil: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 122 Brazil: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 123 Brazil: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 124 Brazil: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 125 Argentina: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 126 Argentina: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 127 Argentina: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 128 Argentina: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Biomarker
  • Figure 7. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Cancer
  • Figure 9. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Technology
  • Figure 11. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2024 & 2034 (USD Billion)
  • Figure 12. Market by End Use
  • Figure 13. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2024 & 2034 (USD Billion)